Boothbay Fund Management, LLC Allakos Inc. Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

A detailed history of Boothbay Fund Management, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 264,102 shares of ALLK stock, worth $248,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264,102

Previous 264,102 -0.0%

Holding current value

$248,255

Previous $264,000 35.23%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.45 $10,636 - $15,422	10,636 Added 4.2%	264,102 $264,000
Q1 2024 May 15, 2024	BUY	$1.02 - $3.23 $205,950 - $652,175	201,912 Added 391.65%	253,466 $319,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $205,724 - $380,350	-119,607 Reduced 69.88%	51,554 $140,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $31,873 - $83,050	14,964 Added 9.58%	171,161 $388,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $512,722 - $747,720	142,423 Added 1034.0%	156,197 $681,000
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $9,713 - $18,681	2,259 Added 19.62%	13,774 $61,000
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $65,174 - $96,956	11,515 New	11,515 $96,000
Q2 2022 Aug 15, 2022	BUY	$2.6 - $6.14 $19,809 - $46,780	7,619 Added 243.73%	10,745 $34,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $46,224 - $66,699	-604 Reduced 16.19%	3,126 $331,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $36,709 - $49,063	430 Added 13.03%	3,730 $318,000
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $362,109 - $507,078	3,300 New	3,300 $379,000
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $205,135 - $280,977	-3,088 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $135,995 - $249,170	3,088 New	3,088 $222,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $1.58 Million - $3.26 Million	-23,688 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $734,328 - $2.13 Million	23,688 New	23,688 $1.86 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $79.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Allakos Inc. Transaction History